| Document and Entity Information | Oct. 28, 2019 |
| Document and Entity Information [Abstract] | |
| Entity Central Index Key | 0001001316 |
| Amendment Flag | false |
| Document Type | 8-K |
| Document Period End Date | Oct. 28, 2019 |
| Entity Registrant Name | TG Therapeutics, Inc. |
| Entity Incorporation, State or Country Code | DE |
| Entity File Number | 001-32639 |
| Entity Tax Identification Number | 36-3898269 |
| Entity Address, Address Line One | 2 Gansevoort Street, 9th Floor |
| Entity Address, City or Town | New York |
| Entity Address, State or Province | NY |
| Entity Address, Postal Zip Code | 10014 |
| City Area Code | 212 |
| Local Phone Number | 554-4484 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.001 |
| Trading Symbol | TGTX |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |
